PMC:7205724 / 829-990 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"57","span":{"begin":21,"end":30},"obj":"Species"},{"id":"58","span":{"begin":62,"end":70},"obj":"Species"},{"id":"69","span":{"begin":83,"end":91},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":21,"end":25},"obj":"Disease"},{"id":"T11","span":{"begin":83,"end":91},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":31,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":136,"end":151},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T5","span":{"begin":136,"end":151},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T11","span":{"begin":21,"end":30},"obj":"Species"},{"id":"T12","span":{"begin":83,"end":91},"obj":"Species"}],"attributes":[{"id":"A11","pred":"ncbi_taxonomy_id","subj":"T11","obj":"NCBItxid:2697049"},{"id":"A12","pred":"ncbi_taxonomy_id","subj":"T12","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"57","span":{"begin":21,"end":30},"obj":"Species"},{"id":"58","span":{"begin":62,"end":70},"obj":"Species"},{"id":"69","span":{"begin":83,"end":91},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"pubann:denotes","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"pubann:denotes","subj":"58","obj":"Tax:9606"},{"id":"A69","pred":"pubann:denotes","subj":"69","obj":"MESH:C000657245"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T129","span":{"begin":2,"end":12},"obj":"NNS"},{"id":"T130","span":{"begin":13,"end":20},"obj":"IN"},{"id":"T131","span":{"begin":21,"end":30},"obj":"NN"},{"id":"T132","span":{"begin":31,"end":34},"obj":"VBZ"},{"id":"T133","span":{"begin":35,"end":40},"obj":"VBN"},{"id":"T134","span":{"begin":41,"end":50},"obj":"JJ"},{"id":"T135","span":{"begin":51,"end":58},"obj":"NNS"},{"id":"T136","span":{"begin":59,"end":61},"obj":"IN"},{"id":"T137","span":{"begin":62,"end":70},"obj":"NNS"},{"id":"T138","span":{"begin":71,"end":75},"obj":"IN"},{"id":"T139","span":{"begin":76,"end":82},"obj":"JJ"},{"id":"T140","span":{"begin":83,"end":91},"obj":"NN"},{"id":"T141","span":{"begin":93,"end":97},"obj":"RB"},{"id":"T142","span":{"begin":97,"end":98},"obj":"-COMMA-"},{"id":"T143","span":{"begin":99,"end":103},"obj":"NNP"},{"id":"T144","span":{"begin":103,"end":104},"obj":"-COMMA-"},{"id":"T145","span":{"begin":105,"end":113},"obj":"VBN"},{"id":"T146","span":{"begin":114,"end":118},"obj":"IN"},{"id":"T147","span":{"begin":119,"end":132},"obj":"NN"},{"id":"T148","span":{"begin":133,"end":135},"obj":"IN"},{"id":"T149","span":{"begin":136,"end":151},"obj":"NNS"},{"id":"T150","span":{"begin":151,"end":152},"obj":"-COMMA-"},{"id":"T151","span":{"begin":153,"end":158},"obj":"MD"}],"relations":[{"id":"R122","pred":"arg1Of","subj":"T129","obj":"T130"},{"id":"R123","pred":"arg2Of","subj":"T131","obj":"T130"},{"id":"R125","pred":"arg2Of","subj":"T133","obj":"T132"},{"id":"R127","pred":"arg2Of","subj":"T135","obj":"T133"},{"id":"R128","pred":"arg1Of","subj":"T135","obj":"T134"},{"id":"R129","pred":"arg1Of","subj":"T133","obj":"T136"},{"id":"R130","pred":"arg2Of","subj":"T137","obj":"T136"},{"id":"R131","pred":"arg1Of","subj":"T137","obj":"T138"},{"id":"R132","pred":"arg2Of","subj":"T140","obj":"T138"},{"id":"R133","pred":"arg1Of","subj":"T140","obj":"T139"},{"id":"R136","pred":"arg1Of","subj":"T143","obj":"T144"},{"id":"R137","pred":"arg2Of","subj":"T143","obj":"T145"},{"id":"R138","pred":"arg1Of","subj":"T145","obj":"T146"},{"id":"R139","pred":"arg2Of","subj":"T147","obj":"T146"},{"id":"R140","pred":"arg1Of","subj":"T147","obj":"T148"},{"id":"R141","pred":"arg2Of","subj":"T149","obj":"T148"},{"id":"R143","pred":"arg1Of","subj":"T143","obj":"T151"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T10","span":{"begin":21,"end":30},"obj":"Disease"},{"id":"T11","span":{"begin":83,"end":91},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"s antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might im"}